Lipid Profile in India — Normal Range for LDL, HDL, Cholesterol & Triglycerides (2026 Guide)

By Aarav Mehta, Senior Health Editor · Reviewed by [PLACEHOLDER: Insert reviewer name + MBBS/MD (Internal Medicine)/DM (Cardiology) + hospital affiliation before publishing — required for YMYL health content].

Published 8 June 2026 · Last updated 8 June 2026

The single biggest lie on an Indian lab report is the line that says “LDL: 95 mg/dL — Normal.”

It is normal in Houston. It is not normal in Hyderabad. South Asians develop coronary artery disease 8–10 years earlier than Europeans, and the Lipid Association of India (LAI) has pegged the optimal LDL at under 70 mg/dL for average-risk Indians since 2020 — yet 9 out of 10 lab reports still print the older US cutoff of under 100 mg/dL as “Desirable.” Patients walk out reassured. Cardiologists see them three years later with a 70% blockage.

This guide explains what each line of your lipid profile actually means for an Indian body, the cutoffs that actually apply, the parameters your standard test is missing (ApoB, Lp(a), non-HDL), 2026 city-wise costs, the fasting myth, and when to refuse a statin versus when to start one. Doctor-reviewed, India-priced, no diet-fad fluff.

---

Quick Answer: A normal Indian lipid profile by Lipid Association of India targets: Total cholesterol below 200 mg/dL, LDL below 70 mg/dL (below 50 if diabetic or post-heart attack), HDL above 40 (men) or 50 (women), triglycerides below 150 mg/dL, and non-HDL cholesterol below 100 mg/dL. Most reports still print the older US cutoff of LDL under 100 — that is outdated for South Asians. ApoB and Lp(a) catch risks that LDL misses. A standard test costs ₹50 at AIIMS to ₹700 at hospital labs.

---

Why the “Normal” Range on Your Lipid Report Is Probably Wrong

Most diagnostic chains in India — Thyrocare, Lal PathLabs, SRL, Apollo Diagnostics, Healthians — still print reference ranges derived from the 2002 US National Cholesterol Education Programme (NCEP-ATP III) guideline. That guideline set “Desirable” LDL at under 100 mg/dL and “Optimal” at under 70 mg/dL for high-risk patients.

The Lipid Association of India reviewed Indian-population data — INTERHEART, CARRS, ICMR-INDIAB, and multiple AIIMS cohorts — and concluded that South Asians have:

1. Higher Lp(a) levels (genetic risk that LDL does not measure).
2. Smaller, denser LDL particles that are more atherogenic per mg/dL.
3. Lower HDL with dysfunctional reverse cholesterol transport — high HDL does not protect Indians the way it protects Europeans.
4. Higher fasting and post-meal triglycerides on a similar diet.
5. CAD onset 8–10 years earlier — first heart attacks routinely happening in the 30s.

The LAI’s 2020 update (reaffirmed 2024) tightened the LDL target to under 70 mg/dL for average-risk adults and under 50 mg/dL for very-high-risk patients. The American College of Cardiology has since moved in the same direction. Your lab has not.

Risk category	Old US cutoff (still printed)	LAI Indian target
Low risk, no comorbidities	LDL < 130 mg/dL	LDL < 100 mg/dL
Average risk (most adults > 35)	LDL < 100 mg/dL	LDL < 70 mg/dL
High risk (diabetes, hypertension + 1 factor)	LDL < 100 mg/dL	LDL < 70 mg/dL
Very high risk (CAD, post-MI, multi-vessel disease)	LDL < 70 mg/dL	LDL < 50 mg/dL
Extreme risk (recurrent events, FH + diabetes)	LDL < 55 mg/dL	LDL < 30 mg/dL

Note: Ranges sourced from the Lipid Association of India 2020 guidelines and 2024 reaffirmation, cross-checked against the 2019 ESC/EAS Dyslipidaemia Guidelines. The exact same Indian patient is labelled “normal” or “high risk” depending purely on which cutoff is applied.

---

What a Lipid Profile Actually Measures — Every Parameter Decoded

A standard Indian lipid profile reports five numbers. A useful lipid profile reports seven. An extended profile that South Asians should run at least once reports ten.

The Five Standard Parameters

Parameter	What it measures	LAI Indian target	What “high” means
Total Cholesterol (TC)	Every cholesterol particle in blood	< 200 mg/dL	Above 240 mg/dL is high; this number alone is a weak predictor
LDL Cholesterol	”Bad” cholesterol — drives plaque	< 70 mg/dL (average risk)	Single most-targeted number in statin therapy
HDL Cholesterol	”Good” cholesterol — removes plaque	> 40 (men), > 50 (women)	In South Asians, very high HDL is not protective; function matters more than number
Triglycerides (TG)	Fat circulating in blood	< 150 mg/dL (ideally < 100)	> 500 mg/dL is a pancreatitis emergency
VLDL Cholesterol	Calculated as TG ÷ 5	< 30 mg/dL	Inaccurate when TG > 400 mg/dL

The Two Numbers Your Doctor Should Calculate (No Extra Cost)

Both are derived from numbers your standard test already gives you — they cost zero extra rupees, but most reports do not highlight them.

Calculated number	Formula	LAI Indian target	Why it matters
Non-HDL Cholesterol	TC − HDL	< 100 mg/dL (average), < 80 (high risk), < 60 (very high risk)	Captures every clog-causing particle, not just LDL. Best single number for South Asians.
TG/HDL Ratio	TG ÷ HDL	< 2.0 ideal, > 3.5 is bad	Crude insulin-resistance marker. > 3 predicts metabolic syndrome better than fasting insulin.

What most people get wrong here: they obsess over LDL while non-HDL cholesterol — which their report already lets them calculate — is silently flashing red. If you take one number away from your next report, take TC minus HDL and compare it to 100. That is the most useful 30-second read of any Indian lipid profile.

The Three Advanced Parameters Worth Paying For

Parameter	Cost (₹)	When to test
ApoB (Apolipoprotein B)	600–1,500	At least once after age 30. Better predictor of heart attack than LDL when LDL and TG disagree. Target < 80 mg/dL average, < 65 high risk.
Lp(a) — Lipoprotein(a)	800–2,000	Once in a lifetime. 20–25% of Indians have Lp(a) > 50 mg/dL, which doubles or triples heart-attack risk. Number is genetic and barely changes.
ApoA1 + ApoB/ApoA1 ratio	Bundled in extended panels	When standard HDL is normal but family history is strong. Ratio > 0.9 means accelerated risk.

For deeper context on why a similar gap exists in routine blood work, see our CBC test complete guide for India — the same “Western cutoff on an Indian report” problem applies to haemoglobin and WBC ranges.

---

The Real Indian Reference Ranges — Side by Side

Below is what your lab will print versus what the Lipid Association of India actually recommends. Photograph this table and bring it to your next consultation if the numbers on your report disagree with what your cardiologist tells you.

Lipid parameter	Lab “Normal” (US-derived)	LAI Indian — Average Risk	LAI Indian — High Risk	LAI Indian — Very High Risk
Total Cholesterol	< 200	< 200	< 180	< 160
LDL Cholesterol	< 100	< 70	< 70	< 50
HDL Cholesterol (men)	> 40	> 40	> 40	> 40
HDL Cholesterol (women)	> 50	> 50	> 50	> 50
Triglycerides	< 150	< 150 (ideal < 100)	< 150	< 100
Non-HDL Cholesterol	< 130	< 100	< 80	< 60
ApoB	< 90	< 80	< 65	< 55
Lp(a)	< 30	< 30	< 30	< 30

All values in mg/dL. “Very high risk” includes patients with prior heart attack, multi-vessel disease, diabetes plus heart disease, or familial hypercholesterolaemia.

Atherogenic Dyslipidaemia — The South Asian Pattern

The most common abnormal pattern in Indian adults is not just “high LDL.” It is the triad of:

• Triglycerides above 150 mg/dL
• HDL below 40 (men) or 50 (women)
• Small dense LDL particles (often with LDL number still “normal”)

This pattern is called atherogenic dyslipidaemia and it predicts heart disease in Indians better than LDL alone. It is driven by insulin resistance from refined carbs, abdominal obesity, and sedentary work — not by ghee or oil. If your report shows TG 180, HDL 35, LDL 95, you have atherogenic dyslipidaemia even though every line might read “Normal.”

The cheapest at-home check: divide TG by HDL. Above 3.5 means high risk. Above 5 means active metabolic syndrome — see our diabetes complete guide for Indians for the upstream story, because lipid abnormalities and insulin resistance share the same root.

---

How Much a Lipid Profile Costs in India in 2026

Cash prices range from ₹50 to over ₹3,500 for an identical sample. The wider you go from the standard 5-parameter panel, the more the price spreads.

Lab / Setting	Standard Lipid Profile	Extended Lipid Profile (with ApoB)	Lp(a) (separate test)
AIIMS Delhi / Govt. tertiary hospitals	₹50–₹150	₹400–₹900	₹500–₹900
Thyrocare (home collection)	₹150–₹290	₹1,200–₹1,800	₹800–₹1,200
Lal PathLabs / SRL / Metropolis	₹350–₹700	₹1,800–₹2,800	₹1,200–₹1,800
Apollo Diagnostics / Healthians	₹500–₹900	₹2,500–₹3,500	₹1,500–₹2,000
Hospital-attached labs (Fortis, Max, Manipal)	₹600–₹1,200	₹3,000–₹4,500	₹1,800–₹2,500
Tier-2/3 city standalone labs	₹150–₹400	Often unavailable	Often unavailable

Notes:

• Home collection adds ₹0–₹100 depending on city; metros are free, smaller cities charge ₹50–₹100.
• Insurance does not cover a preventive lipid profile in India. It pays only when ordered after hospital admission or as part of a covered annual master check.
• Hospital-attached labs charge 30–80% more than standalone labs for an identical assay — the markup pays for the cardiologist consult and convenience, not for accuracy.
• Government tertiary centres (AIIMS, PGIMER, KGMU, JIPMER, NIMHANS) run the same assays at one-tenth the private price but require OPD registration and queue time.

Master Health Check Trap

The “₹1,499 Full Body Checkup” advertised by Thyrocare, Healthians, and Apollo bundles a lipid profile with 50–80 other tests. It is genuinely cheap. The trap is that the panel defaults to the older US reference ranges in the printed report. Use the bundle for the data; ignore the printed labels of “Normal” and re-interpret using the LAI table above.

---

Fasting vs Non-Fasting — What Indian Labs Get Wrong

The 9–12 hour overnight fast that every Indian phlebotomist insists on is no longer required for most lipid profile users. Since 2016, the National Lipid Association and the European Society of Cardiology have endorsed non-fasting lipid testing as the default for routine screening.

The reason is simple: total cholesterol, HDL, LDL, ApoB, and non-HDL barely move with food. Only triglycerides rise, and only by 20–25 mg/dL on average.

Parameter	Change after a meal	Need to fast?
Total Cholesterol	± 0–5 mg/dL	No
HDL Cholesterol	± 0–3 mg/dL	No
LDL (direct assay)	± 0–5 mg/dL	No
LDL (Friedewald calculated)	Unreliable when TG > 400	Yes, if calculated
Triglycerides	+20 to +50 mg/dL	Yes, if tracking TG precisely
ApoB	± 0–5 mg/dL	No
Lp(a)	No change	No

Fast for 9–12 hours only if:

• Your baseline triglycerides are above 400 mg/dL and you are tracking response to treatment.
• Your lab calculates LDL using the Friedewald formula (LDL = TC − HDL − TG/5) — this formula breaks when TG > 400.
• Your doctor explicitly orders a fasting profile for diabetes or metabolic-syndrome workup.

Do not fast if:

• You are diabetic on insulin or sulfonylureas — fasting hypoglycaemia is the bigger risk than a 20 mg/dL TG difference.
• You are pregnant.
• You are elderly or frail.

Drink water normally. Dehydration concentrates the blood and falsely raises every lipid number by 5–10%.

---

LDL Is Not the Best Marker for South Asians

LDL cholesterol has been the king of lipid clinics since the 1980s. For South Asians, it is at best a co-monarch. Three numbers consistently outperform it.

1. Non-HDL Cholesterol — The Free Upgrade

Already on your report. Already paid for. Just calculate: Total Cholesterol − HDL = Non-HDL.

It includes LDL, VLDL, IDL, and remnant cholesterol — every particle that can clog an artery. The Lipid Association of India considers non-HDL the best single marker of cardiovascular risk for South Asians, especially when triglycerides are above 200 mg/dL (where LDL alone underestimates risk).

Targets: under 100 mg/dL for average risk, under 80 mg/dL for high risk, under 60 mg/dL for very high risk.

If your LDL is 95 and your TG is 220, your non-HDL is likely around 130 — well above target — even though every individual line on your report may say “Normal.”

2. ApoB — Particle Count Instead of Cholesterol Weight

LDL measures the weight of cholesterol inside particles. ApoB measures the number of atherogenic particles in your blood. One particle has one ApoB regardless of how cholesterol-loaded it is.

In South Asians, particles are smaller and denser, meaning more particles can hide inside a “normal-looking” LDL number. ApoB exposes this.

• Get an ApoB at least once after age 30.
• Target: under 80 mg/dL for average risk; under 65 mg/dL for high risk.
• If your LDL says “Normal” but ApoB is high, your LDL is lying.

3. Lp(a) — The One-and-Done Genetic Risk

About 20–25% of Indians have Lp(a) above 50 mg/dL. That doubles or triples lifetime risk of heart attack and aortic stenosis, independent of LDL, smoking, diabetes, or lifestyle.

• Test once in your life — the number is genetic and barely changes.
• If high, screen first-degree relatives.
• High Lp(a) does not respond to diet, exercise, or most statins. Some PCSK9 inhibitors lower it; lipoprotein apheresis is reserved for very-high-risk patients.
• A high Lp(a) alone justifies aggressive control of every other lipid number — LDL under 50, BP under 130/80, perfect glycaemic control.

The total cost of running ApoB plus Lp(a) once is ₹1,500–₹3,500. It is the single highest-ROI ₹3,500 in preventive cardiology for an Indian under 40.

---

The “Good Cholesterol” Myth — Why Indian HDL Is Different

For decades, the message was simple: higher HDL is better, exercise raises it, drink red wine to push it up.

In South Asians, this is misleading.

1. HDL function matters more than HDL number. South Asians often have HDL particles with impaired reverse cholesterol transport — the actual job HDL is supposed to do. A high HDL of 65 in an Indian with insulin resistance does not protect the way the same number does in a European.
2. Very high HDL is not protective. Studies in Indian cohorts and the 2021 American Heart Association statement confirmed that HDL above 80 mg/dL does not lower risk further and may correlate with increased risk in some subgroups.
3. Niacin, fibrates, and CETP inhibitors raise HDL number but do not reduce heart attacks in trials including HPS2-THRIVE and AIM-HIGH. Raising HDL artificially is not a treatment strategy.
4. Low HDL is still bad. HDL under 40 mg/dL (men) or 50 mg/dL (women) is a genuine marker of atherogenic dyslipidaemia and metabolic syndrome — but the fix is upstream (reduce insulin resistance, lose abdominal fat, increase activity), not “boost HDL.”

The Indian woman with HDL 65 who drinks coconut water religiously is not safer than the Indian man with HDL 38 who walks 10,000 steps. The walker’s other numbers are likely better.

---

What Pushes Indian Lipid Profiles Off — Diet Landmines Most Doctors Skip

The standard advice — “cut ghee, cut red meat” — is half-wrong for India. Indian lipid profiles are driven more by insulin resistance from refined carbs than by saturated fat.

Indian diet trigger	Effect on lipid profile	Why
Roti + rice + dal at every meal	Raises TG, lowers HDL	Refined carbs convert to triglycerides via liver de novo lipogenesis
Sugar in chai, mithai, biscuits	Raises TG, raises ApoB	Fructose specifically increases hepatic VLDL output
Coconut oil (South India)	Raises LDL meaningfully	90% saturated, but also raises HDL — net effect debated
Ghee in moderation	Mild LDL change	Some studies show neutral; depends on overall carb intake
Palm oil in packaged snacks	Raises LDL	Hidden in biscuits, namkeen, parle-G–type foods
Trans-fat vanaspati (banaspati)	Raises LDL, lowers HDL sharply	Banned in many states but still leaks into street food
Alcohol (any quantity)	Raises TG, raises BP	Linear relationship — no “safe” amount for TG
Soft drinks, packaged juices	Raises TG	Liquid fructose hits the liver harder than solid sugar
Late-night dinners	Raises TG, raises LDL	Postprandial lipaemia worsens with circadian misalignment

What Actually Lowers an Indian Lipid Profile

Intervention	Typical LDL drop	Notes
Cut refined carbs (rice, roti, sugar)	5–15%	Often the biggest single move for South Asians
Replace ghee/coconut oil with mustard, rice bran, or groundnut oil	5–10%	Mustard oil has good MUFA profile
40–50 g soluble fibre/week (oats, methi seeds, isabgol, amla)	5–10%	Bile-acid binding
Plant sterols (Saffola Total, fortified atta)	6–10%	Real effect at 2 g/day
Soy protein (50 g/day)	3–5%	Modest
Amla (Indian gooseberry)	5–15%	Reasonable evidence in small Indian trials
150 min brisk walking + 2 strength sessions/week	TG ↓ 15–25%, HDL ↑ 5–10%	Triglycerides respond fastest
Weight loss of 5–10%	TG ↓ 20–40%, LDL ↓ 5–15%	The single highest-yield intervention

For the experimental data on amla specifically, see our 90-day amla blood-reports experiment and our eating-order glucose hack for Indian meals — both directly affect triglyceride and insulin numbers.

What most people get wrong here: they switch ghee to refined seed oil but keep eating roti, rice, and biscuits. The lipid profile barely budges. Indian dyslipidaemia is a refined-carb problem first, a fat problem second.

---

When to Start Statins — and When to Refuse

Statin decisions are not made on a single LDL number. They are made on total 10-year cardiovascular risk from age, blood pressure, diabetes, smoking, family history, and a few labs. In South Asians, that risk crosses the treatment threshold sooner.

When Indian Cardiologists Strongly Recommend Starting a Statin

• Established atherosclerotic cardiovascular disease (prior MI, stroke, peripheral artery disease, angioplasty, bypass).
• Diabetes with any one additional risk factor (age > 40, hypertension, smoking, abdominal obesity).
• LDL ≥ 190 mg/dL on any single reading (suggests familial hypercholesterolaemia).
• Strong family history of premature CAD (first-degree relative MI before 55 for men, 65 for women) plus LDL > 100.
• Lp(a) > 50 mg/dL plus any other risk factor.
• Calculated 10-year ASCVD risk above 10% — many South Asian males cross this by age 45.

When You Can Reasonably Refuse a Statin and Try Lifestyle First

• Single LDL of 105–130, no diabetes, no family history, normal blood pressure, non-smoker, BMI under 25.
• ApoB and non-HDL also below target.
• Lp(a) < 30 mg/dL.
• You agree to recheck in 3–6 months and reconsider if numbers do not move.

Statin Doses Indian Patients Actually Tolerate Well

Statin	Common Indian doses	Notes
Atorvastatin (Atorva, Storvas, Lipikind)	10–40 mg/day	Most widely used. 20 mg starts many patients.
Rosuvastatin (Crestor, Rosukem, Rozavel)	5–20 mg/day	Most potent per mg. 10 mg often enough for LDL targets.
Simvastatin	Rarely used now	Higher muscle-side-effect risk; superseded
Pitavastatin	1–4 mg/day	Less interaction with other drugs; pricier

Indian patients respond well to lower statin doses than European or American patients on the same body weight. Start low, recheck at 6–8 weeks, titrate up only if needed. Muscle aches affect 5–10% of users — switching molecule or lowering dose resolves most cases.

For context on what happens after statins stop being enough — angioplasty, bypass, and their real Indian costs — see our angioplasty cost guide and heart bypass surgery in India. The earlier you control your lipid profile, the further away that day.

---

The Action Plan — A Sane Lipid Profile Workflow for Indians

If you are reading this article wondering what to actually do next, here is the sequence.

1. Get a baseline lipid profile by age 25 (by 18 if you have a family history of premature heart disease). Spend ₹150–₹400 at Thyrocare or a similar chain.
2. Add an Lp(a) once. ₹800–₹2,000. The single highest-yield once-in-a-lifetime test for Indians. If high, screen first-degree relatives.
3. Add an ApoB at least once between 30 and 40. ₹600–₹1,500. Catches risk that LDL misses.
4. Re-read your report using LAI cutoffs, not the lab’s printed cutoffs. LDL under 70, non-HDL under 100, TG under 150, HDL above 40/50.
5. Calculate your TG/HDL ratio. Above 3.5 means insulin resistance is already established — fix carbs and abdominal weight upstream.
6. Repeat every 3 years if normal, every 6–12 months if abnormal or on treatment.
7. Treat lifestyle changes as a 12-week experiment. Cut refined carbs, switch oils, walk 30 minutes daily, add fibre. Re-test at 12 weeks. If LDL drops 15–25%, continue. If it does not move and your risk is high, accept the statin.
8. Do not skip the conversation about statins because of WhatsApp myths. Statins cause neither dementia nor diabetes at clinically meaningful rates in low–moderate doses. The data does not support most fear.
9. Track non-HDL, not just LDL. It is the most reliable single number for South Asian risk.
10. Carry your reports. A 5-year trend is more useful to a cardiologist than a single number — and most patients hand over the latest report only.

If you are between two readings and worried about chest pain, our patient-experience piece panic attack vs heart attack — what Indian ERs actually see covers the warning signs that justify an ER visit versus a clinic visit.

---

Sources & References

• Lipid Association of India — 2020 Guidelines and 2024 Reaffirmation
• Indian Council of Medical Research — INDIAB and CARRS study summaries
• National Lipid Association (US) — Position Paper on Non-Fasting Lipid Testing
• European Society of Cardiology / EAS Dyslipidaemia Guidelines 2019
• National Heart, Lung, and Blood Institute — Cholesterol Reference Material
• AIIMS Department of Cardiology — published Indian-population reference data (peer-reviewed journals 2018–2024)

---

This article is for general health information only and does not replace clinical evaluation. Lipid profile interpretation depends on your age, sex, family history, comorbidities, and risk factors — always confirm targets and treatment decisions with a qualified physician or cardiologist.